Divestment of the cancer business may be a deterrent for Takeda
Any deal would likely bid Irish rare disease specialist at close to €57bn
Irish domiciled company to get ‘customised training programmes’ from universities
Firm planning to create 150 new jobs in State reports product sales up 110% to $3.4bn
Dublin-headquartered pharma giant is creating 400 jobs as part of the investment
Irish-domiciled business says cost savings in $32bn Baxalta deal 40% more than expected
Shareholders are rejecting proposals to ramp up CEOs’ rewards
Republic a ‘strategically important location’ for the company
Shire shares slide 8% as analysts concerned about ambitious savings target from merger
Deal will give Dublin-based pharma group access to treatment for inflammatory disease
CEO Flemming Ornskov refused to be drawn on whether drugmaker will pitch new higher offer
Shire CEO confident Baxalta shareholders are open to a deal
Investor says shareholders in Dublin company may back increase from current $45.23 a share offer to $50 but some unease over scale of acquisition
YOU MAY ALSO LIKE...
A series examining attitudes North and South about the future of the island
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices